COVID-19 in Pediatrics: A Diagnostic Challenge.

Most pediatric patients with COVID-19 described in the literature have unusual or mild respiratory symptoms. Fever is usually a prominent feature. Cough is described frequently.

Evaluation of BCL2 and TNFα as mRNA biomarkers for monitoring the immune response in critically ill children.

Background: Hospital acquired infection (HAI) and multiple organ dysfunctions (MODS) remain a leading cause of death in pediatric intensive care unit (PICU) despite the great efforts to control it.

Objective: Our objective was to assess the mRNA of TNFα and BCL2 for prediction of HAI and/or MODS in our community.

Patients And Methods: Fifty children, admitted to PICU, were included in the study after exclusion of cases of end-stage renal failure, end-stage liver failure and congenital immune deficiency.

Phosphate disturbance in critically ill children: Incidence, associated risk factors and clinical outcomes.

Background: Hypophosphatemia is one of the common disorders that develop in critically ill patients. It has potential complications and is often unrecognized in those patients.

Objective: Determining the incidence of hypophosphatemia in critically ill children, its association with clinical outcomes and the possible risk factors.